Microcystin-LR Exposure Damages Neurons by Inducing α-Syn Aggregation via MAPK4/GATA2/SNCA and PP2A/GRKs Pathways

Minghao Yan1,2, Huifang Wu1,2, Tong Wu1,2

  • 1State Key Laboratory of Analytical Chemistry for Life Science, Division of Anatomy and Histo-Embryology, Medical School, Nanjing University, Nanjing, 210093, Jiangsu, China.

Molecular Neurobiology
|December 31, 2024
PubMed

Insights

Microcystin-LR (MC-LR), a neurotoxin, promotes Parkinson

Area of Science:

  • Neuroscience
  • Toxicology
  • Molecular Biology

Background:

  • Parkinson's disease (PD) is characterized by dopaminergic neuron loss and Lewy bodies, primarily composed of alpha-synuclein (α-syn).
  • SNCA gene copy number mutations can lead to α-syn overexpression, a factor in PD pathogenesis.
  • Chronic exposure to the neurotoxin Microcystin-LR (MC-LR) has been linked to Parkinson-like symptoms in mice.

Purpose of the Study:

  • To investigate the molecular mechanisms by which MC-LR contributes to Parkinson's disease pathogenesis.
  • To establish and characterize in vivo and in vitro models for studying MC-LR's effects on α-synuclein.
  • To identify specific pathways involved in MC-LR-induced α-synuclein alterations.

Main Methods:

  • Established a 15-month mouse model of chronic MC-LR exposure to assess Lewy body deposition.
  • Developed an in vitro SH-SY5Y cell model of PD exposed to MC-LR.
  • Utilized database analysis to identify transcription factors regulating the SNCA gene and employed molecular assays to confirm pathway interactions.

Main Results:

  • MC-LR exposure led to Lewy body deposition in the mouse model.
  • MC-LR upregulated SNCA gene transcription and α-syn protein expression via the MAPK4/GATA2 pathway.
  • MC-LR inhibited PP2A activity and activated GRKs, promoting α-syn phosphorylation at Ser129.

Conclusions:

  • MC-LR exposure promotes α-synuclein (α-syn) elevation and aggregation, contributing to Parkinson's disease pathogenesis.
  • The MAPK4/GATA2 pathway mediates MC-LR-induced enhancement of SNCA transcription and subsequent α-syn upregulation.
  • The PP2A/GRKs pathway is involved in MC-LR-induced α-syn phosphorylation, further implicating MC-LR in PD pathology.